Abstract

Conference Article| August 01 1995 Human tumour antigens recognized by T-cells: perspectives for new cancer vaccines B. Van den Eynde; B. Van den Eynde * 1Ludwig Institute for Cancer Research, Brussels Branch, 74 avenue Hippocrate, B-1200 Brussels, Belgium, and Cellular Genetics Unit, Université Catholique de Louvain, B-1200 Brussels, Belgium *To whom correspondence should be addressed Search for other works by this author on: This Site PubMed Google Scholar B. Gaugler; B. Gaugler 1Ludwig Institute for Cancer Research, Brussels Branch, 74 avenue Hippocrate, B-1200 Brussels, Belgium, and Cellular Genetics Unit, Université Catholique de Louvain, B-1200 Brussels, Belgium Search for other works by this author on: This Site PubMed Google Scholar P. van der Bruggen; P. van der Bruggen 1Ludwig Institute for Cancer Research, Brussels Branch, 74 avenue Hippocrate, B-1200 Brussels, Belgium, and Cellular Genetics Unit, Université Catholique de Louvain, B-1200 Brussels, Belgium Search for other works by this author on: This Site PubMed Google Scholar P. Coulie; P. Coulie 1Ludwig Institute for Cancer Research, Brussels Branch, 74 avenue Hippocrate, B-1200 Brussels, Belgium, and Cellular Genetics Unit, Université Catholique de Louvain, B-1200 Brussels, Belgium Search for other works by this author on: This Site PubMed Google Scholar V. Brichard; V. Brichard 1Ludwig Institute for Cancer Research, Brussels Branch, 74 avenue Hippocrate, B-1200 Brussels, Belgium, and Cellular Genetics Unit, Université Catholique de Louvain, B-1200 Brussels, Belgium Search for other works by this author on: This Site PubMed Google Scholar T. Boon T. Boon 1Ludwig Institute for Cancer Research, Brussels Branch, 74 avenue Hippocrate, B-1200 Brussels, Belgium, and Cellular Genetics Unit, Université Catholique de Louvain, B-1200 Brussels, Belgium Search for other works by this author on: This Site PubMed Google Scholar Biochem Soc Trans (1995) 23 (3): 681–686. https://doi.org/10.1042/bst0230681 Article history Received: March 03 1995 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Cite Icon Cite Get Permissions Citation B. Van den Eynde, B. Gaugler, P. van der Bruggen, P. Coulie, V. Brichard, T. Boon; Human tumour antigens recognized by T-cells: perspectives for new cancer vaccines. Biochem Soc Trans 1 August 1995; 23 (3): 681–686. doi: https://doi.org/10.1042/bst0230681 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsBiochemical Society Transactions Search Advanced Search Keywords: CTL, cytolytic T-lymphocyte, DOPA, dihydroxyphenyl alanine, EBV, Epstein-Barr virus, LAK, lymphocyte-activated killer, MHC, major histocompatability complex, MLTC, mixed lymphocyte-tumour cultures, NK, natural killer, RT-PCR, reverse transcription-polymerase chain reaction, TIL, tumour-infiltrating lymphocyte, TNF, tumour necrosis factor This content is only available as a PDF. © 1995 Biochemical Society1995 Article PDF first page preview Close Modal You do not currently have access to this content.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call